Live from the NIH registry
Studies recruiting near Lafayette right now
Top 25 of 61 recruiting studies, sorted by proximity — each links to its official registry page
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Cancer Center of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: NRG Oncology
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 961 participants sought
GSK Investigational Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: GlaxoSmithKline
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Gastroenterology Clinic of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 3
Interventional 460 participants sought
Gastroenterology Clinic of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Sparrow Pharmaceuticals
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: AstraZeneca
Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers
Venous Leg Ulcer, Chronic Wounds
N/A
Interventional 122 participants sought
MedCentris of Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: NuScience Medical Biologics, LLC
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Phase 3
Interventional 6,950 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: AstraZeneca
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms
Phase 2
Interventional 308 participants sought
Southern Urology, LLC ( Site 0145) — Lafayette, Louisiana (1.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Velocity Clinical Research, Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Pfizer
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, Human
Phase 3
Interventional 54,000 participants sought
GSK Investigational Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: GlaxoSmithKline
Tissue Repair Gel in Venous Leg Ulcers (US)
Venous Leg Ulcer, Venous Ulcer
Phase 3
Interventional 312 participants sought
Clincial Research Site 01 — Lafayette, Louisiana (1.3 mi)
· Sponsor: TR Therapeutics
Continuous Dual Aspiration Technique With Zoom System for Stroke
Ischemic Stroke, Acute Stroke
N/A
Observational 750 participants sought
Ochsner Clinic Foundation (Lafayette) — Lafayette, Louisiana (1.3 mi)
· Sponsor: Imperative Care, Inc.
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
Cervical Carcinoma, Human Papillomavirus Infection
N/A
Interventional 500 participants sought
Louisiana State University — Lafayette, Louisiana (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: DalCor Pharmaceuticals
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Abbeville General Hospital — Abbeville, Louisiana (17.2 mi)
· Sponsor: NRG Oncology
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Phase 3
Interventional 220 participants sought
Southern Urology LLC — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
The THOR IDE Study
Peripheral Artery Disease, Peripheral Artery Stenosis
N/A
Interventional 155 participants sought
Cardiovascular Institute of the South — Lafayette, Louisiana (1.3 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
Pneumococcal Disease
Phase 3
Interventional 1,200 participants sought
Velocity Clinical Research, Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Pfizer
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
Idiopathic Short Stature
Phase 2
Interventional 100 participants sought
Velocity Clinical Research - MedPharmics - Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: BioMarin Pharmaceutical
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Southern Urology — Lafayette, Louisiana (1.3 mi)
· Sponsor: Pacific Edge Limited
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Abbeville General Hospital — Abbeville, Louisiana (17.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Chronic Spontaneous Urticaria (CSU)
Phase 3
Interventional 400 participants sought
Velocity Clinical Research — Lafayette, Louisiana (1.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Asthma
Phase 2
Interventional 69 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: AstraZeneca
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Abbeville General Hospital — Abbeville, Louisiana (17.2 mi)
· Sponsor: NRG Oncology